Source:http://linkedlifedata.com/resource/pubmed/id/11149669
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2001-1-8
|
| pubmed:databankReference | |
| pubmed:abstractText |
The blood-brain barrier (BBB) is formed by the brain microvascular endothelium, and the unique transport properties of the BBB are derived from tissue-specific gene expression within this cell. The current studies developed a gene microarray approach specific for the BBB by purifying the initial mRNA from isolated rat brain capillaries to generate tester cDNA. A polymerase chain reaction-based subtraction cloning method, suppression subtractive hybridization (SSH), was used, and the BBB cDNA was subtracted with driver cDNA produced from mRNA isolated from rat liver and kidney. Screening 5% of the subtracted tester cDNA resulted in identification of 50 gene products and more than 80% of those were selectively expressed at the BBB; these included novel gene sequences not found in existing databases, ESTs, and known genes that were not known to be selectively expressed at the BBB. Genes in the latter category include tissue plasminogen activator, insulin-like growth factor-2, PC-3 gene product, myelin basic protein, regulator of G protein signaling 5, utrophin, IkappaB, connexin-45, the class I major histocompatibility complex, the rat homologue of the transcription factors hbrm or EZH1, and organic anion transporting polypeptide type 2. Knowledge of tissue-specific gene expression at the BBB could lead to new targets for brain drug delivery and could elucidate mechanisms of brain pathology at the microvascular level.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jan
|
| pubmed:issn |
0271-678X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
61-8
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:11149669-Animals,
pubmed-meshheading:11149669-Blood-Brain Barrier,
pubmed-meshheading:11149669-Brain,
pubmed-meshheading:11149669-Capillaries,
pubmed-meshheading:11149669-Cerebrovascular Circulation,
pubmed-meshheading:11149669-Cloning, Molecular,
pubmed-meshheading:11149669-Genomics,
pubmed-meshheading:11149669-Glioma,
pubmed-meshheading:11149669-In Situ Hybridization,
pubmed-meshheading:11149669-Kidney,
pubmed-meshheading:11149669-Liver,
pubmed-meshheading:11149669-Molecular Sequence Data,
pubmed-meshheading:11149669-Myocardium,
pubmed-meshheading:11149669-Nerve Tissue Proteins,
pubmed-meshheading:11149669-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:11149669-Organ Specificity,
pubmed-meshheading:11149669-Polymerase Chain Reaction,
pubmed-meshheading:11149669-RNA, Messenger,
pubmed-meshheading:11149669-Rats,
pubmed-meshheading:11149669-Tumor Cells, Cultured
|
| pubmed:year |
2001
|
| pubmed:articleTitle |
Blood-brain barrier genomics.
|
| pubmed:affiliation |
Department of Medicine, UCLA School of Medicine, Los Angeles, California 90095-1682, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|